Our environment
Partner platforms
Screening
- Strasbourg Platform for Integrative Chemistry and Biology (PCBIS)
- Download the platform sheet - Screening Platform for Bio-Active Molecules (CMBA), CEA Grenoble - Download the platform sheet
- High-throughput screening and combinatorial chemistry platform, CEA Saclay
- Ariadne platform - Download the platform sheet
- Plateforme Centre de Découverte et de Développement du Médicament (C3D) (Drug Discovery and Development Center) - Download the platform sheet
- BioPhenics cell screening platform - Platform Institut Curie
- Screening Platform at the Institut de la Vision - Download the platform sheet
- ChemBioFrance infrastructure
- Prestwick Chemical- Greenpharma
- PhenoFish platform -Download the platform sheet
- I-Stem platform - Download the platform sheet
- Therrassay platform - Download the platform sheet
- Paris Saclay Screening Platform (C@PS) - Download the platform sheet
- CBC Biological Screening Platform and Chemical Libraries - Download the platform sheet
- Marseille-Luminy screening platform
- Pharmacology Interactome Screening Platform
- ImPACcell platform - Download the platform sheet
- Toulouse integrated screening platform (PICT)
- IGBMC high-throughput cell screening platform - Download the platform sheet
- Screenia platform - Medetia SAS - Download the platform sheet
- Biogenouest
High-speed sequencing
- Imagine Genomics / Institute of Genetic Diseases, Paris -
- Genomeast, IGBMC, Strasbourg -
- Integragen, Evry -
- Biogenouest Genomics, Nantes -
Creation of experimental models
- Phenomin Infrastructure : Institut Clinique de la Souris, Strasbourg , CIPHE (Center for ImmunoPHEnogenomics), Marseille - Download the platform sheet
- Platform Rat Transgenesis and Immunophenomics TRIP Nantes - Download the platform sheet
- Platform SEGiCel , Lyon - Download the platform sheet
- Platform iPSC Nantes - Download the platform sheet
- Zebrafish platform Tefor Paris Saclay - Download the platform sheet
For projects based on specific technological approaches concerning screening, high-throughput sequencing or the creation of experimental models, partnerships can be extended to other platforms.
Contact us: aap-bio(@)fondation-maladiesrares.com